Adenosine signaling during acute and chronic disease states
Reads0
Chats0
TLDR
Key observations are discussed that define the beneficial and detrimental aspects of adenosine signaling during acute and chronic disease states with an emphasis on cellular processes, such as inflammatory cell regulation, vascular barrier function, and tissue fibrosis.Abstract:
Adenosine is a signaling nucleoside that is produced following tissue injury, particularly injury involving ischemia and hypoxia. The production of extracellular adenosine and its subsequent signaling through adenosine receptors plays an important role in orchestrating injury responses in multiple organs. There are four adenosine receptors that are widely distributed on immune, epithelial, endothelial, neuronal,and stromal cells throughout the body. Interestingly, these receptors are subject to altered regulation following injury. Studies in mouse models and human cells and tissues have identified that the production of adenosine and its subsequent signaling through its receptors plays largely beneficial roles in acute disease states, with the exception of brain injury. In contrast, if elevated adenosine levels are sustained beyond the acute injury phase, adenosine responses can become detrimental by activating pathways that promote tissue injury and fibrosis. Understanding when during the course of disease adenosine signaling is beneficial as opposed to detrimental and defining the mechanisms involved will be critical for the advancement of adenosine-based therapies for acute and chronic diseases. The purpose of this review is to discuss key observations that define the beneficial and detrimental aspects of adenosine signaling during acute and chronic disease states with an emphasis on cellular processes, such as inflammatory cell regulation, vascular barrier function, and tissue fibrosis.read more
Citations
More filters
Journal ArticleDOI
Postnatal development and LPS responsiveness of pulmonary adenosine receptor expression and of adenosine-metabolizing enzymes in mice
Juhani Metsola,Mikael Maksimow,Marja Ojaniemi,Hanna Metsola,Fumiko Marttila-Ichihara,Reetta Vuolteenaho,Gennady G. Yegutkin,Marko Salmi,Mikko Hallman,Sirpa Jalkanen +9 more
TL;DR: Low pulmonary CD73 expression, L PS-induced suppression of A2A, LPS-induced increase of A1 expression, and severe respiratory distress were distinguishing responses in the newborns from those in the adults.
Journal ArticleDOI
Targeting purinergic receptors to suppress the cytokine storm induced by SARS-CoV-2 infection in pulmonary tissue
Júlia Leão Batista Simões,Helena Fornari Basso,Greicy Cristine Kosvoski,Jullye Gavioli,Filomena Marafon,Charles Elias Assmann,Fabiano B. Carvalho,Margarete Dulce Bagatini +7 more
TL;DR: The etiological agent of coronavirus disease (COVID-19) is the new member of the Coronaviridae family, a severe acute respiratory syndrome (SARS-CoV-2) responsible for the pandemic that is plaguing the world.
Journal ArticleDOI
Characterization of Dahl salt-sensitive rats with genetic disruption of the A2B adenosine receptor gene: implications for A2B adenosine receptor signaling during hypertension
Shraddha Nayak,Md. Abdul Hye Khan,Tina C. Wan,Hong Pei,Joel Linden,Melinda R. Dwinell,Aron M. Geurts,John D. Imig,John A. Auchampach +8 more
TL;DR: The authors' data indicate varying roles for A2BAR signaling in regulating blood pressure in SS rats, playing both anti- and prohypertensive roles depending on the pathogenic mechanisms that contribute to blood pressure elevation.
Journal ArticleDOI
Ultrasensitive detection of small biomolecules using aptamer-based molecular recognition and nanoparticle counting.
TL;DR: In this paper , a new method for detecting small biomolecules based on molecular recognition and nanoparticle counting is proposed, where aptamer-functionalized NPs are attached to complementary sequence-conjugated microparticle (MP) carriers.
Journal ArticleDOI
Dual Actions of A2A and A3 Adenosine Receptor Ligand Prevents Obstruction-Induced Kidney Fibrosis in Mice
TL;DR: In this article, a dual-acting ligand that is an A2AAR agonist and an A3AR antagonist was used to prevent the progression of tubulointerstitial fibrosis.
References
More filters
Journal ArticleDOI
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio,Karen M. Dwyer,Wenda Gao,David J. Friedman,Anny Usheva,Anna Erat,Jiang-Fan Chen,Keiichii Enjyoji,Joel Linden,Mohamed Oukka,Vijay K. Kuchroo,Terry B. Strom,Simon C. Robson +12 more
TL;DR: It is concluded that CD39 and CD73 are surface markers of T reg cells that impart a specific biochemical signature characterized by adenosine generation that has functional relevance for cellular immunoregulation.
Journal ArticleDOI
Hypoxia and Inflammation
TL;DR: This review deals with emerging evidence of an association between systemic or local hypoxia and inflammation in a variety of diseases and points to new ways of treating inflammatory disorders or conditions such as certain cancers with intralesional Hypoxia.
Journal ArticleDOI
Adenosine receptors as therapeutic targets
Kenneth A. Jacobson,Zhan-Guo Gao +1 more
TL;DR: Recent advances in the understanding of the roles of the various adenosine receptor subtypes, and in the development of selective and potent ligands, have brought the goal of therapeutic application of adenosines receptor modulators considerably closer.
Journal ArticleDOI
Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage.
Akio Ohta,Michail V. Sitkovsky +1 more
TL;DR: It is suggested that A2a adenosine receptors are a critical part of the physiological negative feedback mechanism for limitation and termination of both tissue-specific and systemic inflammatory responses.
Journal ArticleDOI
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and Classification of Adenosine Receptors—An Update
TL;DR: In the 10 years since the previous International Union of Basic and Clinical Pharmacology report on the nomenclature and classification of adenosine receptors, no developments have led to major changes in the recommendations, but there have been so many other developments that an update is needed.